文献速递膀胱癌与上尿路尿路上皮癌

膀胱癌术后膀胱内化疗灌注依从性的影响因素

What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer?
PubMed 文献 · BJU Int · 2021-03-28

本研究采用行为理论框架,在苏格兰和英格兰七家医院开展横断面描述性研究,访谈30名负责SI-IVC的泌尿科员工,分析影响非肌层浸润性膀胱癌切除术后单次膀胱内化疗灌注依从性的障碍与促进因素,发现障碍涉及多个组织层面和专业角色,苏格兰的国家治理框架可能带来改善。

要点

  • SI-IVC的障碍包括剧院不灌注政策、MMC订购和储存延迟、缺乏培训与感知工作负荷。
  • 促进因素包括现代灌注设备、手术记录中的提醒以及国家治理框架下的绩效目标。
  • 改善依从性需调整剧院政策、MMC供应储存、员工培训和文档记录。

核心结论

  • 高确定性证据表明NMIBC切除术后SI-IVC可减少复发,但合格患者接受SI-IVC的比例可变,实践不理想。
  • 改善SI-IVC依从性需要修改剧院灌注政策、MMC递送与储存、员工培训及文档记录。
  • 在苏格兰,集中化护理、膀胱癌专家领导、最佳实践分享与绩效目标可能带来改善。

研究设计与样本

  • 横断面描述性研究,调查七家医院的实践、护理路径和政策,并访谈30名负责SI-IVC的泌尿科员工。
  • 使用理论域框架(TDF)组织调查,进行演绎主题分析,并归纳编码新出现的信念。

主要发现

  • 四家医院有不在手术室行SI-IVC的政策。
  • 六家医院员工报告丝裂霉素C(MMC)订购和/或本地储存延迟。
  • 缺乏培训、技能和感知工作负荷影响动机。
  • 四家医院获得现代灌注设备,四家医院在手术记录中加入提醒。
  • 苏格兰存在国家治理框架下的绩效目标(含审计和反馈),英格兰没有。

临床怎么用

  • 建议修改手术室灌注政策,优化MMC递送与储存流程。
  • 加强员工培训,并在手术记录中嵌入提醒以促进SI-IVC执行。
  • 可借鉴苏格兰经验,推行集中化护理、专家领导、最佳实践分享与绩效目标。
  • 实施国家质量改进项目,结合审计和反馈,并针对专业角色采取实施策略。
  • 实施过程应受控以明确干预效果。

局限性

  • 本研究为横断面描述性研究,仅纳入七家医院和30名员工,结果可能不具广泛代表性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To understand the barriers and facilitators to single instillation of intravesical chemotherapy (SI-IVC) use after resection of non-muscle-invasive bladder cancer (NMIBC) in Scotland and England using a behavioural theory-informed approach. SUBJECTS AND METHODS: In a cross-sectional descriptive study of practices at seven hospitals, we investigated care pathways, policies, and interviewed 30 urology staff responsible for SI-IVC. We used the Theoretical Domains Framework (TDF) to organise our investigation and conducted deductive thematic analyses, while inductively coding emergent beliefs. RESULTS: Barriers to SI-IVC were present at different organisational levels and professional roles. In four hospitals, there was a policy to not instil SI-IVC in theatre. Six hospitals' staff reported delays in mitomycin C (MMC) ordering and/or local storage. Lack of training, skills and perceived workload affected motivation. Facilitators included access to modern instilling devices (four hospitals) and incorporating reminders in operation proforma (four hospitals). Performance targets (with audit and feedback) within a national governance framework were present in Scotland but not England. Differences in coordinated leadership, sharing best practices, and disliking being perceived as underperforming, were evident in Scotland. CONCLUSIONS: High-certainty evidence shows that SI-IVC, such as MMC, after NMIBC resection reduces recurrences. This evidence underpins international guidance. The number of eligible patients receiving SI-IVC is variable indicating suboptimal practice. Improving SI-IVC adherence requires modifications to theatre instilling policies, delivery and storage of MMC, staff training, and documentation. Centralising care, with bladder cancer expert leadership and best practices sharing with performance targets, likely led to improvements in Scotland. National quality improvement, incorporating audit and feedback, with additional implementation strategies targeted to professional role could improve adherence and patient outcomes elsewhere. This process should be controlled to clarify implementation intervention effectiveness.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Dunsmore J, Duncan E, Mariappan P, et al. What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer? BJU Int. 2021. PMID: 33450116. doi:10.1111/bju.15336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。